IP Library Assignment 029908/0145
Patent Assignment
Reel/Frame 029908/0145

Assignment of Assignor's Interest

Recorded: 2013-03-01 Pages: 4
Assignor
BAYER PHARMA AKTIENGESELLSCHAFT
Executed: 2012-04-01
Assignee
BAYER INTELLECTUAL PROPERTY GMBH
ALFRED NOBEL STRASSE 10, MONHEIM, 40789, GERMANY
Covered Properties (29)
Process for Preparing Nifedipine
Patent: 6,294,673 →
Application: 09/446,478 →
Medicament Formulation with a Controlled Release of an Active Agent
Patent: 6,270,799 →
Application: 09/508,868 →
Osmotic Medicament Releasing System
Patent: 6,294,201 →
Application: 09/530,158 →
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Patent: 6,362,178 →
Application: 09/554,162 →
Dihydropyrimidines
Patent: 6,696,451 →
Application: 09/673,592 →
Method for producing (s,s)-benzyl-2,8-diazabicyclo[4.3.0]nonane
Patent: 6,235,908 →
Application: 09/700,107 →
2-Phenyl Substituted Imidatriazinones as Phosphodiesterase Inhibitors
Patent: 6,566,360 →
Application: 09/943,530 →
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Patent: 6,890,922 →
Application: 10/365,740 →
Publication: US 2004/0067945
Method for Producing 8-Methoxy-Quinoline Carboxylic Acids
Patent: 6,897,315 →
Application: 10/406,129 →
Publication: US 2003/0208069
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Patent: 7,122,540 →
Application: 10/923,544 →
Publication: US 2005/0070541
Method for Producing 8-Methoxy-Quinoline Carboxylic Acids
Patent: 7,115,744 →
Application: 11/127,811 →
Publication: US 2005/0209276
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors, for Treatment of Hypertension
Patent: 7,314,871 →
Application: 11/409,417 →
Publication: US 2006/0189615
3,5-Difluoropyridines
Patent: 7,514,565 →
Application: 11/639,955 →
Publication: US 2007/0117812
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Patent: 7,704,999 →
Application: 12/004,933 →
Publication: US 2008/0113972
Fused Bicyclic Imidazoles
Patent: 8,592,591 →
Application: 12/191,706 →
Publication: US 2009/0156604
Dimeric Molecular Complexes
Patent: 8,501,185 →
Application: 12/302,283 →
Publication: US 2011/0104058
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Patent: 7,696,206 →
Application: 12/569,720 →
Publication: US 2010/0016323
New Modulating Molecules for an Improved Regulated Expression System
Application: 12/594,941 →
Publication: US 2011/0020925
Alkynylaryl Compounds and Salts Thereof, Pharmaceutical Compositions Comprising Same, Methods of Preparing Same and Uses of Same
Patent: 8,481,539 →
Application: 12/747,880 →
Publication: US 2010/0261730
Medication for Oral Administration, Comprising at Least One Estrogen and/or at Least One Gestagen and at Least One Probiotic Bacterial Strain
Application: 13/322,131 →
Publication: US 2012/0189599
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Application: 13/429,588 →
Publication: US 2013/0059844
Branched 3-Phenylpropionic Acid Derivatives and Their Use
Patent: 8,796,335 →
Application: 13/431,934 →
Publication: US 2013/0079412
New Binder-Drug Conjugates (Adcs) and Use Thereof
Application: 13/451,950 →
Publication: US 2013/0066055
Neutralizing Prolactin Receptor Antibodies and Their Therapeutic Use
Application: 13/514,991 →
Publication: US 2012/0321632
Neutralizing Prolactin Receptor Antibodies and Their Therapeutic Use
Patent: 9,649,374 →
Application: 13/514,992 →
Publication: US 2013/0272968
Neutralizing Prolactin Receptor Antibodies and Their Therapeutic Use
Application: 13/514,993 →
Publication: US 2013/0171147
Neutralizing Prolactin Receptor Antibodies and Their Therapeutic Use
Application: 13/514,994 →
Publication: US 2012/0315276
Neutralizing Prolactin Receptor Antibodies and Their Therapeutic Use
Application: 13/514,995 →
Publication: US 2013/0022606
Neutralizing Prolactin Receptor Antibodies and Their Therapeutic Use
Patent: 9,241,989 →
Application: 13/514,996 →
Publication: US 2013/0129739
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 2, 2009
From: HOLDER, SWEN; ZULCH, ARMIN; BAR, THOMAS; MAIER, THOMAS
To: BAYER SCHERING PHARMA AG
Reel/Frame 022187/0808 →
Merger Jun 24, 2009
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 022868/0365 →
Assignment of Assignor's Interest Jul 15, 2009
From: HEITNER, TARA; LIGHT, DAVID; MCLEAN, KIRK; PARRY, RENATE
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 022959/0196 →
Merger Jan 12, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023769/0122 →
Change of Name Oct 28, 2011
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 027139/0709 →
Change of Name Apr 23, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 028093/0091 →
Confirmatory Assignment Apr 23, 2012
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 028093/0393 →
Change of Name Apr 12, 2013
From: BAYER SCHERING PHARMA AG
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 030202/0001 →
Assignment of Assignor's Interest Apr 15, 2013
From: HARTUNG, INGO, DR.; BRIEM, HANS, DR.; KETTSCHAU, GEORG, DR.; THIERAUCH, KARL-HEINZ, DR.
To: BAYER SCHERING PHARMA AG
Reel/Frame 030213/0173 →
Assignment of Assignor's Interest Apr 15, 2013
From: LINDEMANN, STEFANIE, DR.; GENERAL, SASCHA, DR.
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 030212/0863 →